Cargando…
Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
Small studies suggest that amiodarone is a weak inhibitor of cytochrome P450 (CYP) 2D6. Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the enzyme, such as metoprolol. Considering that both metoprolol and amiodarone have β‐adrenergic blocking properties and that the...
Autores principales: | Robert, Sabrina, Pilon, Marc‐Olivier, Oussaïd, Essaïd, Meloche, Maxime, Leclair, Grégoire, Jutras, Martin, Gaulin, Marie‐Josée, Mongrain, Ian, Busseuil, David, Tardif, Jean‐Claude, Dubé, Marie‐Pierre, de Denus, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512912/ https://www.ncbi.nlm.nih.gov/pubmed/37732835 http://dx.doi.org/10.1002/prp2.1137 |
Ejemplares similares
-
Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
por: Hindi, Jessica, et al.
Publicado: (2023) -
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study
por: Meloche, Maxime, et al.
Publicado: (2022) -
An association study of
ABCG2
rs2231142 on the concentrations of allopurinol and its metabolites
por: Pilon, Marc‐Olivier, et al.
Publicado: (2022) -
Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
por: Vaidya, Varun, et al.
Publicado: (2012) -
Mitochondrial Disorder Aggravated by Metoprolol
por: Samuels, Cheryl, et al.
Publicado: (2016)